7-OH Kratom Detox
Our Evidence-Based Detox Protocol
Comprehensive Assessment
Medication-Assisted Withdrawal
24/7 Clinical Monitoring
Continuous vital signs and symptom scoring
Dynamic medication adjustments
Holistic & Psychosocial Support
Individual and group therapy (CBT, motivational interviewing)
Mind-body modalities: yoga, meditation
Nutritional counseling & fitness planning
Aftercare & Continuing Recovery
Residential or PHP/IOP Transition: Seamless handoff ensures stability.
Peer Support & Alumni Networks
Family Education & Aftercare Planning
To Learn about 7-OH Kratom: What It Is, Why Officials Are Cracking Down, and Warning Signs You Can’t Ignore- Click the Link Below to Read Our Blog on
Dangerous New Kratom Derivative—What You Need to Know About 7-OH (7-Hydroxymitragynine)
What Is 7-OH Kratom?
7-Hydroxymitragynine (7-OH or 7-HMG) is a minor—but highly potent—alkaloid metabolite of mitragynine in the kratom plant. Unlike raw kratom, certain “enhanced” products concentrate 7-OH up to 13–46× the potency of mitragynine and even exceed morphine’s efficacy.
Risks & Potency
Opioid-Like Agonism: 7-OH binds opioid receptors with high efficacy, producing strong analgesia and euphoria—raising overdose and dependence risk.
Unregulated Manufacturing: Sold as “7-HMG,” gummies, or resin concentrates without quality controls, leading to unpredictable dosing and contamination.
Rapid Tolerance & Dependence: Even short-term use of 7-OH extracts can precipitate physical dependence similar to prescription opioids.
Withdrawal Symptoms & Timeline
Kratom withdrawal mirrors opioid withdrawal but may onset faster with 7-OH:
PhaseOnsetKey Symptoms
Early 12–24 hrs
Anxiety, restlessness, myalgia, insomnia
Peak 24–72hrs
Nausea, vomiting, diarrhea, sweating, tremors
Late4–14 days
Cravings, mood swings, sleep disturbance
FAQs
-
7-OH (7-hydroxymitragynine) is a concentrated opioid-like alkaloid derived from kratom that is far more potent than the whole leaf. Unlike traditional kratom, 7-OH products often behave like synthetic opioids, increasing risk of dependence and overdose
-
Federal health authorities, including recent statements from Robert F. Kennedy Jr.’s administration, have raised alarms about the opioid-like potency, unregulated distribution, and rising misuse of concentrated 7-OH products—prompting moves toward Schedule I classification to curb emerging harms.
-
Signs include increased tolerance, cravings, secretive use, withdrawal-like irritability, sedation, mood swings, and difficulty functioning without the substance.
-
Yes. Because of its potency and inconsistent labeling, 7-OH can depress breathing, cause unconsciousness, and lead to fatal overdose—especially when combined with other depressants.
-
Withdrawal mirrors opioid withdrawal: muscle aches, nausea, vomiting, anxiety, insomnia, sweating, and intense cravings. Medically supervised detox significantly improves safety and outcomes.
-
Yes. MAT (e.g.,Suboxone®/buprenorphine) can be part of a clinically supervised detox to reduce cravings and ease withdrawal while clients stabilize mentally and physically.
-
Encourage a medical evaluation, avoid judgmental language, ensure they have naloxone available, and help them connect to a supervised detox program. Remove unregulated products from their environment if safe to do so.